PCOS has a new name. As of this week, it’s officially PMOS – Polyendocrine Metabolic Ovarian Syndrome

It’s about endocrine disruption. Metabolism. It’s a whole-body syndrome that has been misrepresented by its own name since the day it was labeled.

That matters more than it appears. Because names shape what gets studied, what gets funded, what gets taught to medical professionals, and what ultimately gets believed.

The 170 million estimated women who experience PMOS have spent years being told their symptoms don’t quite add up, being handed a diagnosis that didn’t explain what they were actually living, and walking away with more questions than answers.

Here’s what I’ve learned building Ourself: no two women’s hormones are the same. Not even close. Two women can carry the same diagnosis and have almost nothing in common in terms of symptoms, severity, triggers, or what helps. The label was always a ceiling, not a map.

Renaming this condition is an act of honesty. It says: we were wrong about what this is and you – the patient – deserve a framework that actually reflects your reality.

But a new name, on its own, won’t reach the woman who doesn’t have a doctor to call. It won’t find the woman who was diagnosed years ago and has been navigating this alone ever since. It won’t close the information gap that most women with hormonal conditions live inside every single day.

That’s the part that’s up to us: not just better language, but better access. Better tools. Research that finally takes women’s bodies seriously in all their variation.

This renaming is a beginning. I hope the field keeps it going.